Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: Evidence from homologous versus heterologous binding analysis

FEBS Letters

Volumn 399, Issue 3, 1996, Pages 264-266

  Hastrup, Hanne ^a,b   Schwartz, Thue W ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

7TM receptor; Ligand binding; Neurokinin A; Neuropeptide; Septide; Substance P

Indexed keywords

NEUROKININ 1 RECEPTOR; NEUROKININ A; SEPTIDE; SUBSTANCE P; TACHYKININ;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CELL STRAIN COS1; DRUG RECEPTOR BINDING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; COS CELLS; MOLECULAR SEQUENCE DATA; NEUROKININ A; PEPTIDE FRAGMENTS; PROTEIN BINDING; PYRROLIDONECARBOXYLIC ACID; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

ANIMALIA;

EID: 0030590846     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(96)01337-3     Document Type: Article

References (21)

1. [1] Regoli, D., Boudon, A. and Fauchere, J.L. (1994) Pharmacol. Rev. 46, 551-599.
2. [2] Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M. and Nakanishi, S. (1987) Nature 329, 836-838.
3. [3] Yokota, Y., Sasai, Y., Tanaka, K., Fujiwara, T., Tsuchida, K., Shigemoto, R., Kakizuka, A., Ohkubo, H., and Nakanishi, S. (1989) J. Biol. Chem. 264, 17649-17652.
4. [4] Shigemoto, R., Yokota, Y., Tsuchida, K. and Nakanishi, S. (1990) J. Biol. Chem. 265, 623-629.
5. [5] Wormser, U., Laufer, R., Hart, Y., Chorev, M., Gilon, C., and Selinger, Z. (1986) EMBO J. 5, 2805-2808.
6. [6] Lee, C.M., Cambell, N.J., Williams, B.J. and Iversen, L.L. (1986) Eur. J. Pharmacol. 130, 209-217.
7. [7] Yanagisawa, M. and Otsuka, M. (1990) Br. J. Pharmacol. 100, 711-716.
8. [8] Maggi, C.A., Patacchini, R., Meini, S. and Giuliani, S. (1993) Eur. J. Pharmacol. 235, 309-311.
9. [9] Meini, S., Patacchini, R. and Maggi, C.A. (1994) Br. J. Pharmacol. 111, 739-746.
10. [10] Petitet, F., Saffroy, M., Torrens, Y., Lavielle, S., Chassaing, G., Loeuillet, D., Glowinski, J. and Beaujoan, J.C. (1992) Peptides 13, 383-388.
11. [11] Glowinski, J. (1995) Trends Pharmacol. Sci. 16, 365-367.
12. [12] Cascieri, M., Huang, R.R.C., Fong, T.M., Cheung, A.H., Sadowski, S., Ber, E. and Strader, C.D. (1992) Mol. Pharmacol. 41, 1096-1099.
13. [13] Fong, T.M., Yu, H., Huang, R.R.C. and Strader, C.D. (1992) Biochemistry 31, 11806-11811.
14. [14] Pradier, L., Menager, J., Le Guern, J., Bock, M.D., Heuillet, E., Fardin, V., Garret, C., Doble, A. and Mayaux, J.F. (1994) Mol. Pharmacol. 45, 287-293.
15. [15] Sagan, S., Chassaing G., Pradier, L. and Lavielle S. (1996) J. Pharm. Exp. Ther. 276, 1039-1048.
16. [16] Huang, R.R.C., Yu, H., Strader, C.D. and Fong, T.M. (1994) Biochemistry 33, 3007-3013.
17. [17] Rosenkilde, M.M., Cahir, M., Gether, U., Hjorth, S.A. and Schwartz, T.W. (1994) J. Biol. Chem. 269, 28160-28164.
18. [18] Hjorth, S.A., Thirstrup, K. and Schwartz, T.W. (1996) Mol. Pharmacol. 50, 977-984.
19. [19] Gether, U., Johansen, T.E. and Schwartz, T.W. (1993) J. Biol. Chem. 268, 7893-7898.
20. [20] Huang, R.R.C., Vicario, P.P., Strader, C.D. and Fong, T.M. (1995) Biochemistry 34, 10048-10055.
21. [21] Tian, Y., Wu, L.-H., Oxender, D.L. and Chung, F.-Z. (1996) J. Biol. Chem. 271, 20250-20257.